Subject: Strong Prescription Numbers and Overall Revenue for RXMD

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
Strong Prescription Numbers and Overall Revenue for RXMD
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Last:

Price: 0.0739

Change (%): + 0.0029 (4.08)

Volume: 386,886
RXMD Chart

Progressive Care Inc. Continues to See Strong Prescription Numbers and Overall Revenue in May 2018

MIAMI, June 14, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of prescriptions filled for May 2018.

Progressive Care’s wholly owned subsidiary PharmCo, LLC has seen an 18.75% increase in prescriptions filled over the same month last year, totaling approximately 22,300 prescriptions.

May brought a total net revenue of roughly 1.78 million dollars: a slight decrease of 4.6% from May 2017, due to decreased reimbursement rates on compounds and the transition of more patients to the company’s 340B model that decreases sales but maintains profitability due to dispensing fees. However, looking at the total revenue combined for April and May, Progressive Care shows an increase of 2.4% compared to last year.

“As we come out of another month of substantial growth we continue to dedicate ourselves to providing our patients a full range of personalized medication therapies,” said S. Parikh Mars, CEO of Progressive Care Inc. “As reimbursement compression across the medication spectrum remains, Progressive Care has devoted itself to increasing revenues with continued sales efforts, medication diversification, and further expansion of our service offerings.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks